Jlohr Brain Health
  • Home
  • About Us
  • Brain Health Diagnoses
  • Resources on this Site
    • Drug Discount Services
    • With Each Diagnosis:
      • YouTube Video
      • Book from Library or Amazon
      • Support Group or Service
    • Tables for Patients:
      • Special Education
      • Social Security Disability Income
      • School Aid
    • Tables for Patients or Professionals
      • Overview of 9 Aspects of this Diagnosis
      • DSM-5’s First Pages and ICD-10’s Billing Codes
  • Medical & Educational Downloads
  • Contact Us
Select Page

Factors associated with end-of-life quality in terminally ill cancer patients’ last six months of life: a longitudinal study

by jlohrconsulting | Nov 5, 2025 | Uncategorized

Support Care Cancer. 2025 Nov 5;33(12):1016. doi: 10.1007/s00520-025-10057-z. ABSTRACT CONTEXT/PURPOSE: Promoting high-quality end-of-life (EOL) care is crucial for cancer patients. We investigated underexplored predictors associated with EOL quality and its domains...

The quality of life of students is impacted by the quality of life of senior surgeons in French university hospitals

by jlohrconsulting | Nov 5, 2025 | Uncategorized

Langenbecks Arch Surg. 2025 Nov 5;411(1):4. doi: 10.1007/s00423-025-03873-8. ABSTRACT INTRODUCTION: Quality of life of medical school students is impaired by anxiety or depression. As they spend more than of their time as assistants in the hospitals, it is expected...

Long COVID and psychosocial factors among middle-aged and older adults. Results of the nationally representative German Ageing Survey

by jlohrconsulting | Nov 5, 2025 | Uncategorized

Aging Clin Exp Res. 2025 Nov 5;37(1):313. doi: 10.1007/s40520-025-03246-7. ABSTRACT BACKGROUND: In addition to the physical symptoms, long COVID can cause considerable psychological burden. AIMS: To investigate the association of long COVID with depressive symptoms,...

Introduction to the special issue: Gut microbiota modulation – a new factor in the treatment of neurodevelopmental and neurodegenerative diseases

by jlohrconsulting | Nov 5, 2025 | Uncategorized

Pharmacol Rep. 2025 Nov 5. doi: 10.1007/s43440-025-00797-4. Online ahead of print. NO ABSTRACT PMID:41191310 | DOI:10.1007/s43440-025-00797-4

Esketamine for Treatment-Resistant Depression-Reply

by jlohrconsulting | Nov 5, 2025 | Uncategorized

JAMA Psychiatry. 2025 Nov 5. doi: 10.1001/jamapsychiatry.2025.3248. Online ahead of print. NO ABSTRACT PMID:41191340 | DOI:10.1001/jamapsychiatry.2025.3248

Esketamine for Treatment-Resistant Depression

by jlohrconsulting | Nov 5, 2025 | Uncategorized

JAMA Psychiatry. 2025 Nov 5. doi: 10.1001/jamapsychiatry.2025.3242. Online ahead of print. NO ABSTRACT PMID:41191347 | DOI:10.1001/jamapsychiatry.2025.3242
« Older Entries
Next Entries »

Recent Posts

  • Dissociative Drug-Induced Anxiety
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)
  • Associations in intentions to use anabolic-androgenic steroids among non-consuming boys and men with probable eating disorders and muscle dysmorphia
  • Assessing schema modes for eating disorders and their association with personality traits: validation of the English version of the short form of the schema modes inventory for eating disorders (EN-SMI-ED-SF)

Recent Comments